Literature DB >> 9278253

Moderately controlled transport of ascorbate into aortic endothelial cells against slowdown of the cell cycle, decreasing of the concentration or increasing of coexistent glucose as compared with dehydroascorbate.

Y Saitoh1, N Nagao, R O'Uchida, T Yamane, K Kageyama, N Muto, N Miwa.   

Abstract

Uptake of L-[1-(14)C]ascorbic acid (Asc) of 12.5-200 microM for 1 h into bovine aortic endothelial BAE-2 cells grown to confluence was as low as 43-64% (per cell) of uptake into the cells grown to nearly one-fourth confluence. [14C]Asc undergoing transmembrane uptake was concentrated and accumulated in the cell less efficiently ([Asc]in/ex = 8-13) at confluence than at subconfluence ([Asc]in/ex = 15-24). The declined Asc uptake at confluence is attributable to slowdown of the cell cycle, because a similar decrease in [Asc]in/ex was shown by subconfluent cells precultured in serum-insufficient medium, resulting in an increase in G1 phase and concurrent decreases in S and G2 + M phase distributions as determined by flow cytometry. [1-(14)C]Dehydroascorbic acid (DehAsc) was taken up and accumulated as Asc, after metabolic reduction, without detectable DehAsc. The [Asc]in/ex values for DehAsc at confluence were as low as 15-69% of those at subconfluence in contrast to the values as retentive as 62-75% for Asc, suggesting the moderate control of Asc uptake against slowdown of the cell cycle. At either confluence or subconfluence, dose-dependence for DehAsc uptake was more marked than for Asc uptake as shown by an uphill slope in a curve of doses versus [Asc]in/ex for DehAsc in contrast to a downhill slope for Asc, suggesting the moderate control for Asc uptake against fluctuation of the dose. Increasing of coexistent glucose of 5 mM to 20-40 mM, plasma concentrations in diabetic patients, declined DehAsc uptake to 46-48%, which was less moderately controlled than Asc uptake retained to 59-73%. Asc uptake did not compete with DehAsc uptake, suggesting different transporter proteins for Asc and DehAsc. Thus, Asc uptake into the aortic endothelial cells is more moderately controlled against slowdown of the cell cycle, decreasing of the extracellular concentrations or increasing of coexistent glucose than DehAsc uptake, suggesting a homeostatic advantage of Asc over DehAsc in terms of retention of intracellular Asc contents within a definite range.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278253     DOI: 10.1023/a:1006879001316

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Differential susceptibility of epidermal keratinocytes and neuroblastoma cells to cytotoxicity of ultraviolet-B light irradiation prevented by the oxygen radical-scavenger ascorbate-2-phosphate but not by ascorbate.

Authors:  T Kanatate; N Nagao; M Sugimoto; K Kageyama; T Fujimoto; N Miwa
Journal:  Cell Mol Biol Res       Date:  1995

2.  Ascorbate-stimulated active Na+ transport in rabbit ciliary epithelium.

Authors:  O A Candia; X P Shi; T C Chu
Journal:  Curr Eye Res       Date:  1991-03       Impact factor: 2.424

3.  Sodium-dependent ascorbic and dehydroascorbic acid uptake by SV-40-transformed retinal pigment epithelial cells.

Authors:  K W Lam; H S Yu; R D Glickman; T Lin
Journal:  Ophthalmic Res       Date:  1993       Impact factor: 2.892

4.  Active transport of ascorbic acid across the retinal pigment epithelium of the bullfrog.

Authors:  J DiMattio; J Streitman
Journal:  Curr Eye Res       Date:  1991-10       Impact factor: 2.424

5.  The uptake of ascorbic acid into human umbilical vein endothelial cells and its effect on oxidant insult.

Authors:  A Ek; K Ström; I A Cotgreave
Journal:  Biochem Pharmacol       Date:  1995-10-26       Impact factor: 5.858

6.  Inhibition of ascorbic acid transport in human neutrophils by glucose.

Authors:  P Washko; M Levine
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

7.  Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum.

Authors:  K R Dhariwal; W O Hartzell; M Levine
Journal:  Am J Clin Nutr       Date:  1991-10       Impact factor: 7.045

8.  Adaptive regulation of ascorbate transport in osteoblastic cells.

Authors:  S J Dixon; J X Wilson
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741

9.  Effect of hypoxia-reoxygenation on peroxisomal functions in cultured human skin fibroblasts from control and Zellweger syndrome patients.

Authors:  K Kremser; M Kremser-Jezik; I Singh
Journal:  Free Radic Res       Date:  1995-01

10.  Ascorbic acid uptake by isolated rat hepatocytes. Stimulatory effect of diquat, a redox cycling compound.

Authors:  M C Cornu; G A Moore; Y Nakagawa; P Moldéus
Journal:  Biochem Pharmacol       Date:  1993-10-19       Impact factor: 5.858

View more
  3 in total

1.  Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamin C via hydrolytic conversion into ascorbate.

Authors:  Masahiro Eguchi; Takashi Miyazaki; Eiko Masatsuji-Kato; Toshi Tsuzuki; Tomohiro Oribe; Nobuhiko Miwa
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  Development of ascorbate transporters in brain cortical capillary endothelial cells in culture.

Authors:  Huan Qiao; James M May
Journal:  Brain Res       Date:  2008-03-18       Impact factor: 3.252

3.  Resveratrol potentiates intracellular ascorbic acid enrichment through dehydroascorbic acid transport and/or its intracellular reduction in HaCaT cells.

Authors:  Yasukazu Saitoh; Taiki Umezaki; Nene Yonekura; Atsushi Nakawa
Journal:  Mol Cell Biochem       Date:  2020-02-21       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.